Adiso
Adiso Therapeutics — Advancing Novel Therapies For Inflammatory Diseases
United States · Founded 2022 · $60.0M raised
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- adisotx.com
- Total Funding
- $60.0M
- Last Round
- $60.0M SeedMar 2022
- Rounds
- 1
About
Clinical-stage biotech developing novel therapies for inflammatory diseases.
Summary
Adiso is a Biotech company based in United States, founded in 2022. It has raised $60.0M in total across 1 round, most recently a $60.0M Seed round in Mar 2022. Investors include Morningside Group.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...